000			02255 a2200601 4500
005			20250513095012.0
264		0	_c19960917
008			199609s 0 0 eng d
022			_a0022-1767
040			_aNLM _beng _cNLM
100	1		_aMacari, D M
245	0	0	_aPriming of eosinophil recruitment in vivo by LPS pretreatment. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cAug 1996
300			_a1684-92 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAntigens, CD _xgenetics
650	0	4	_aAzepines _xpharmacology
650	0	4	_aCD18 Antigens _ximmunology
650	0	4	_aChemotactic Factors, Eosinophil _xpharmacology
650	0	4	_aChemotaxis, Leukocyte _xdrug effects
650	0	4	_aComplement C5a, des-Arginine _xpharmacology
650	0	4	_aCycloheximide _xpharmacology
650	0	4	_aDrug Synergism
650	0	4	_aEdema _xchemically induced
650	0	4	_aEosinophilia _xchemically induced
650	0	4	_aEosinophils _xdrug effects
650	0	4	_aFemale
650	0	4	_aGuinea Pigs
650	0	4	_aImmunoglobulin G _xpharmacology
650	0	4	_aInterleukin 1 Receptor Antagonist Protein
650	0	4	_aLeukocyte Count _xdrug effects
650	0	4	_aLeukotriene B4 _xpharmacology
650	0	4	_aLipopolysaccharides _xpharmacology
650	0	4	_aLipoxygenase Inhibitors _xpharmacology
650	0	4	_aNeutrophils _xdrug effects
650	0	4	_aPassive Cutaneous Anaphylaxis
650	0	4	_aPlatelet Activating Factor _xantagonists & inhibitors
650	0	4	_aProtein Synthesis Inhibitors _xpharmacology
650	0	4	_aPyrans _xpharmacology
650	0	4	_aQuinolones _xpharmacology
650	0	4	_aReceptors, Tumor Necrosis Factor _xgenetics
650	0	4	_aReceptors, Tumor Necrosis Factor, Type I
650	0	4	_aRecombinant Fusion Proteins _xpharmacology
650	0	4	_aSialoglycoproteins _xpharmacology
650	0	4	_aSkin _xdrug effects
650	0	4	_aTriazoles _xpharmacology
650	0	4	_aZymosan _xpharmacology
700	1		_aTeixeira, M M
700	1		_aHellewell, P G
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 157 _gno. 4 _gp. 1684-92
999			_c8756658 _d8756658